Feline Hypoproteinemia: Causes, Diagnosis, and Management

Feline hypoproteinemia is a laboratory finding of decreased total protein or albumin concentration in the blood, indicating an underlying disease process that requires systematic investigation. This article provides veterinary clinicians with a structured approach to diagnosing the cause of low protein in cats, differentiating protein-losing enteropathy, protein-losing nephropathy, hepatic insufficiency, and other etiologies, and implementing appropriate management strategies. The content is based on published veterinary literature and clinical guidelines, with emphasis on practical diagnostic workup, interpretation of laboratory findings, and treatment of the primary disease.

At a Glance: Feline Hypoproteinemia Decision Framework

Pathophysiology of Hypoproteinemia in Cats

Total protein in feline serum consists of albumin and globulins. Albumin is synthesized exclusively by the liver and represents the largest fraction. Globulins include alpha, beta, and gamma fractions produced by the liver and immune cells. Hypoproteinemia results from one of four mechanisms: decreased production, increased loss, redistribution, or dilution. In cats, the most clinically relevant causes are protein-losing enteropathy (PLE), protein-losing nephropathy (PLN), hepatic insufficiency, and malnutrition. Each mechanism requires a distinct diagnostic approach and management strategy.

Albumin has a half-life of approximately 8 to 10 days in cats. Low albumin triggers compensatory mechanisms including increased hepatic synthesis and reduced catabolism. When albumin falls below 2.0 g/dL, oncotic pressure decreases, leading to peripheral edema, ascites, or pleural effusion. Globulin concentrations provide additional diagnostic information. Low globulins with low albumin suggest a synthetic defect such as liver failure. Normal or elevated globulins with low albumin suggest protein loss or consumption.

The Merck Veterinary Manual provides guidance on diagnostic approaches for feline disorders. The American College of Veterinary Internal Medicine (ACVIM) publishes consensus statements on protein-losing diseases. The International Cat Care guidelines from catvets.com offer practical recommendations for feline medicine.

Diagnostic Workup for Feline Hypoproteinemia

Initial Laboratory Assessment

The first step is to confirm hypoproteinemia with a complete blood count, serum biochemistry profile, and urinalysis. Total protein and albumin are measured directly. Globulin is calculated by subtracting albumin from total protein. A low total protein with low albumin and low globulins points to a synthetic problem. Low albumin with normal or high globulins points to a loss or consumption problem.

Serum biochemistry should include liver enzymes (ALT, AST, ALP, GGT), bilirubin, bile acids, blood urea nitrogen, creatinine, glucose, electrolytes, and calcium. Urinalysis should include specific gravity, dipstick, and sediment examination. Proteinuria is assessed with a urine protein:creatinine (UPC) ratio. A UPC greater than 0.5 in cats is abnormal and suggests glomerular disease.

Differentiating Protein-Losing Enteropathy from Protein-Losing Nephropathy

PLE and PLN are the two most common causes of feline hypoproteinemia. Differentiation relies on history, physical examination, and laboratory findings. Cats with PLE typically present with chronic diarrhea, vomiting, weight loss, or poor coat quality. Cats with PLN may have no gastrointestinal signs but show polyuria, polydipsia, or hypertension. Both conditions can cause edema or effusion.

Fecal Alpha-1 Protease Inhibitor Testing

Fecal alpha-1 protease inhibitor (fAI) is a protein that leaks into the intestinal lumen when there is protein loss. It is resistant to degradation and can be measured in feces. A high fAI concentration supports a diagnosis of PLE. This test is noninvasive and can be performed on a single fecal sample. It is particularly useful when intestinal biopsy is not feasible or when the cat is unstable for anesthesia.

Intestinal Biopsy

Definitive diagnosis of PLE requires histopathologic examination of intestinal tissue. Endoscopic biopsy is less invasive than full-thickness surgical biopsy but may not sample deeper layers. Full-thickness biopsy provides more complete information but carries higher risk. Biopsy samples should be submitted for routine histopathology, immunohistochemistry for infectious agents, and possibly culture. Common histopathologic findings in feline PLE include lymphocytic-plasmacytic enteritis, eosinophilic enteritis, and intestinal lymphoma.

Renal Biopsy

When PLN is suspected based on persistent proteinuria and hypoalbuminemia, renal biopsy may be indicated to confirm glomerular disease and guide treatment. Biopsy is performed under ultrasound guidance or surgically. Samples are evaluated by light microscopy, immunofluorescence, and electron microscopy. Common glomerular diseases in cats include membranous glomerulonephritis, membranoproliferative glomerulonephritis, and amyloidosis.

Hepatic Function Testing

Hepatic insufficiency is diagnosed by measuring serum bile acids, ammonia, and liver enzymes. Pre- and post-prandial bile acids are the most sensitive test for liver function. A bile acid stimulation test involves measuring bile acids before and two hours after feeding. Elevated bile acids indicate portosystemic shunting or hepatocellular dysfunction. Liver biopsy is required for definitive diagnosis of hepatic disease.

Protein-Losing Enteropathy in Cats

Causes of Feline PLE

PLE in cats is caused by diseases that disrupt the intestinal mucosal barrier, allowing protein to leak into the gut lumen. Common causes include:

• Inflammatory bowel disease (IBD): lymphocytic-plasmacytic enteritis, eosinophilic enteritis, neutrophilic enteritis
• Intestinal lymphoma: alimentary lymphoma is the most common type in cats
• Infectious enteritis: feline coronavirus (FIP), histoplasmosis, pythiosis, salmonellosis, giardiasis
• Intestinal neoplasia: adenocarcinoma, mast cell tumor
• Lymphangiectasia: dilated intestinal lymphatics causing protein loss
• Chronic enteropathy: a broad term for persistent intestinal inflammation

The Veterinary Clinics of North America: Small Animal Practice published a review on protein-losing enteropathies in dogs, which provides a framework applicable to cats. The Frontiers in Veterinary Science article on canine chronic enteropathy discusses emerging concepts relevant to feline PLE.

Clinical Signs of Feline PLE

Cats with PLE present with chronic gastrointestinal signs including diarrhea, vomiting, weight loss, and poor appetite. Some cats have no diarrhea and present only with weight loss or edema. Physical examination may reveal thin body condition, poor coat quality, abdominal distension from ascites, or peripheral edema. Rectal examination may show thickened intestinal loops.

Diagnostic Confirmation of PLE

Diagnosis of PLE requires demonstration of intestinal protein loss and exclusion of other causes. The diagnostic workup includes:

1. Serum biochemistry: low albumin, normal or low globulins, normal liver enzymes
2. Urinalysis: no proteinuria or low UPC ratio
3. Fecal alpha-1 protease inhibitor: elevated
4. Abdominal ultrasound: thickened intestinal wall, loss of layering, lymphadenopathy
5. Intestinal biopsy: histopathologic confirmation of underlying disease

Management of Feline PLE

Management of PLE focuses on treating the underlying disease and providing nutritional support. Dietary modification is the cornerstone of therapy. A highly digestible, low-residue diet with moderate protein content is recommended. Some cats benefit from a novel protein or hydrolyzed protein diet. Omega-3 fatty acids and probiotics may have adjunctive benefits.

Immunosuppressive therapy is indicated for IBD. Prednisolone is the first-line agent. Chlorambucil or cyclosporine may be added for refractory cases. Antibiotics are used for infectious causes. Chemotherapy is indicated for lymphoma. The Veterinary Clinics of North America: Small Animal Practice article on treating hypoalbuminemia provides guidance on albumin supplementation.

Monitoring and Prognosis for PLE

Cats with PLE require regular monitoring of body weight, body condition score, serum albumin, and clinical signs. Albumin concentration is a useful marker of disease activity. Relapse is common, and long-term management is often necessary. Prognosis depends on the underlying cause. IBD has a fair to good prognosis with appropriate therapy. Lymphoma has a guarded prognosis.

Protein-Losing Nephropathy in Cats

Causes of Feline PLN

PLN in cats is caused by glomerular diseases that increase permeability of the glomerular filtration barrier, allowing protein to leak into the urine. Common causes include:

• Glomerulonephritis: immune complex deposition, membranous glomerulonephritis, membranoproliferative glomerulonephritis
• Amyloidosis: deposition of amyloid fibrils in the glomerulus
• Feline infectious peritonitis (FIP): immune complex deposition
• Chronic inflammatory disease: secondary glomerular injury
• Neoplasia: paraneoplastic glomerulopathy

Clinical Signs of Feline PLN

Cats with PLN present with signs of chronic kidney disease including polyuria, polydipsia, weight loss, and poor appetite. Some cats have no clinical signs until advanced disease. Physical examination may reveal thin body condition, dehydration, hypertension, or retinal detachment. Edema and ascites are less common than in PLE.

Diagnostic Confirmation of PLN

Diagnosis of PLN requires demonstration of persistent proteinuria and exclusion of other causes. The diagnostic workup includes:

1. Serum biochemistry: low albumin, normal globulins, elevated BUN and creatinine
2. Urinalysis: proteinuria, low specific gravity, inactive sediment
3. Urine protein:creatinine ratio: greater than 0.5
4. Blood pressure measurement: hypertension is common
5. Renal biopsy: histopathologic confirmation of glomerular disease

Management of Feline PLN

Management of PLN focuses on reducing proteinuria and preserving renal function. Angiotensin-converting enzyme inhibitors (ACEi) such as enalapril or benazepril are first-line therapy. Angiotensin receptor blockers (ARBs) such as telmisartan are alternatives. Dietary protein restriction is recommended to reduce glomerular filtration pressure. Omega-3 fatty acids may have renoprotective effects.

Immunosuppressive therapy is indicated for immune-mediated glomerulonephritis. Prednisolone, cyclophosphamide, or mycophenolate mofetil may be used. Chemotherapy is indicated for paraneoplastic glomerulopathy. Supportive care includes management of hypertension, electrolyte imbalances, and uremia.

Monitoring and Prognosis for PLN

Cats with PLN require regular monitoring of body weight, body condition score, serum creatinine, UPC ratio, and blood pressure. Proteinuria is a marker of disease activity and progression. Relapse is common, and long-term management is often necessary. Prognosis depends on the underlying cause and stage of disease. Glomerulonephritis has a guarded to poor prognosis. Amyloidosis has a poor prognosis.

Hepatic Insufficiency and Hypoproteinemia

Causes of Hepatic Hypoproteinemia

Hepatic insufficiency causes hypoproteinemia due to decreased synthesis of albumin and globulins. Common causes in cats include:

• Hepatic lipidosis: severe fatty infiltration of the liver
• Cholangiohepatitis: inflammation of bile ducts and liver parenchyma
• Cirrhosis: end-stage liver disease with fibrosis
• Portosystemic shunt: congenital or acquired
• Hepatic neoplasia: lymphoma, adenocarcinoma
• Toxic hepatopathy: drug-induced or toxin-induced liver injury

The Veterinary Clinics of North America: Small Animal Practice article on feline hepatic lipidosis provides detailed information on this condition.

Clinical Signs of Hepatic Hypoproteinemia

Cats with hepatic insufficiency present with signs of liver disease including jaundice, vomiting, diarrhea, weight loss, and poor appetite. Some cats have neurologic signs from hepatic encephalopathy. Physical examination may reveal icterus, hepatomegaly, ascites, or neurologic abnormalities.

Diagnostic Confirmation of Hepatic Hypoproteinemia

Diagnosis of hepatic insufficiency requires demonstration of decreased liver function and exclusion of other causes. The diagnostic workup includes:

1. Serum biochemistry: low albumin, low globulins, elevated liver enzymes, elevated bilirubin
2. Bile acids: elevated pre- and post-prandial
3. Ammonia: elevated
4. Abdominal ultrasound: hepatomegaly, hyperechoic liver, biliary abnormalities
5. Liver biopsy: histopathologic confirmation of underlying disease

Management of Hepatic Hypoproteinemia

Management of hepatic insufficiency focuses on treating the underlying liver disease and providing nutritional support. Dietary modification is essential. A high-quality, highly digestible protein source is recommended. Protein restriction is indicated for hepatic encephalopathy. Vitamin K supplementation is indicated for cholestasis.

Specific therapy depends on the underlying cause. Hepatic lipidosis requires aggressive nutritional support, often with a feeding tube. Cholangiohepatitis requires antibiotics and immunosuppressive therapy. Cirrhosis requires supportive care and management of complications. Portosystemic shunt requires surgical ligation or medical management.

Monitoring and Prognosis for Hepatic Hypoproteinemia

Cats with hepatic insufficiency require regular monitoring of body weight, body condition score, serum albumin, liver enzymes, bile acids, and ammonia. Albumin concentration is a marker of liver function. Relapse is common, and long-term management is often necessary. Prognosis depends on the underlying cause and stage of disease. Hepatic lipidosis has a fair to good prognosis with aggressive therapy. Cirrhosis has a poor prognosis.

Malnutrition and Malabsorption

Causes of Nutritional Hypoproteinemia

Malnutrition and malabsorption cause hypoproteinemia due to inadequate protein intake or absorption. Common causes in cats include:

• Starvation: inadequate food intake
• Poor quality diet: low protein content
• Malabsorption: pancreatic insufficiency, small intestinal disease
• Chronic disease: cancer, chronic infection, chronic inflammation
• Hypermetabolic states: hyperthyroidism, diabetes mellitus

Clinical Signs of Nutritional Hypoproteinemia

Cats with nutritional hypoproteinemia present with signs of poor nutrition including weight loss, poor coat quality, muscle wasting, and lethargy. Some cats have no clinical signs until advanced disease. Physical examination reveals thin body condition, poor muscle mass, and poor coat quality.

Diagnostic Confirmation of Nutritional Hypoproteinemia

Diagnosis of nutritional hypoproteinemia requires demonstration of inadequate protein intake or absorption and exclusion of other causes. The diagnostic workup includes:

1. Dietary history: inadequate intake, poor quality diet
2. Serum biochemistry: low albumin, normal globulins, normal liver enzymes
3. Urinalysis: no proteinuria
4. Fecal alpha-1 protease inhibitor: normal
5. Pancreatic function testing: trypsin-like immunoreactivity, feline pancreatic lipase immunoreactivity

Management of Nutritional Hypoproteinemia

Management of nutritional hypoproteinemia focuses on providing adequate protein intake. Dietary modification is the cornerstone of therapy. A high-quality, highly digestible protein source is recommended. Nutritional supplementation may be necessary. Appetite stimulants or feeding tubes may be required for cats with poor appetite.

Monitoring and Prognosis for Nutritional Hypoproteinemia

Cats with nutritional hypoproteinemia require regular monitoring of body weight, body condition score, and serum albumin. Albumin concentration is a marker of nutritional status. Prognosis is good with appropriate nutritional support.

Other Causes of Hypoproteinemia in Cats

Chronic Inflammation and Neoplasia

Chronic inflammation and neoplasia can cause hypoproteinemia through increased protein catabolism, decreased synthesis, or protein loss. The Veterinary Clinics of North America: Small Animal Practice article on laboratory abnormalities in patients with cancer discusses this topic. Common causes include:

• Chronic infection: feline leukemia virus, feline immunodeficiency virus, toxoplasmosis, histoplasmosis
• Chronic inflammatory disease: pancreatitis, cholangiohepatitis, inflammatory bowel disease
• Neoplasia: lymphoma, adenocarcinoma, mast cell tumor

Fluid Overload and Dilution

Fluid overload from intravenous fluids, blood transfusions, or ascites can cause dilutional hypoproteinemia. This is a transient finding that resolves with correction of the fluid imbalance.

Blood Loss

Acute or chronic blood loss from trauma, surgery, or gastrointestinal bleeding can cause hypoproteinemia. This is usually accompanied by anemia.

Practical Implementation Steps for Diagnosing Feline Hypoproteinemia

Step 1: Confirm Hypoproteinemia

Obtain a complete blood count, serum biochemistry profile, and urinalysis. Measure total protein and albumin. Calculate globulin. Repeat testing to confirm persistent hypoproteinemia.

Step 2: Assess Clinical Signs

Take a thorough history including diet, appetite, weight loss, vomiting, diarrhea, polyuria, polydipsia, and medication use. Perform a complete physical examination including body condition score, hydration status, abdominal palpation, and rectal examination.

Step 3: Differentiate Protein Loss from Synthetic Defect

Use the albumin-to-globulin ratio to differentiate protein loss from synthetic defect. Low albumin with normal or high globulins suggests protein loss. Low albumin with low globulins suggests synthetic defect.

Step 4: Evaluate for Protein-Losing Enteropathy

If PLE is suspected, perform fecal alpha-1 protease inhibitor testing. Consider abdominal ultrasound and intestinal biopsy.

Step 5: Evaluate for Protein-Losing Nephropathy

If PLN is suspected, perform urine protein:creatinine ratio. Consider renal biopsy.

Step 6: Evaluate for Hepatic Insufficiency

If hepatic insufficiency is suspected, perform bile acids and ammonia testing. Consider liver biopsy.

Step 7: Evaluate for Malnutrition

If malnutrition is suspected, take a detailed dietary history. Consider pancreatic function testing.

Step 8: Treat Underlying Disease

Implement specific therapy for the underlying cause. Provide nutritional support. Monitor response to therapy.

Records and Measurements for Feline Hypoproteinemia

Essential Records

Maintain accurate records of:

• Body weight and body condition score at each visit
• Serum albumin and total protein concentrations
• Urine protein:creatinine ratio
• Fecal alpha-1 protease inhibitor results
• Intestinal or renal biopsy results
• Dietary history and changes
• Medication history and doses
• Clinical signs and response to therapy

Monitoring Parameters

Monitor the following parameters at regular intervals:

• Serum albumin: every 2 to 4 weeks initially, then every 1 to 3 months
• Body weight: every 2 to 4 weeks
• Body condition score: every 2 to 4 weeks
• Urine protein:creatinine ratio: every 1 to 3 months
• Blood pressure: every 1 to 3 months
• Liver enzymes and bile acids: every 1 to 3 months
• Fecal alpha-1 protease inhibitor: as needed

Common Failure Patterns in Managing Feline Hypoproteinemia

Failure to Identify the Underlying Cause

The most common failure is treating hypoproteinemia without identifying the underlying cause. This leads to ineffective therapy and disease progression. Always perform a thorough diagnostic workup before initiating treatment.

Inadequate Nutritional Support

Cats with hypoproteinemia require adequate protein intake. Failure to provide nutritional support leads to continued protein loss and poor outcomes. Use feeding tubes if necessary.

Inappropriate Dietary Protein Restriction

Protein restriction is indicated for PLN and hepatic encephalopathy but is contraindicated for PLE and malnutrition. Inappropriate protein restriction worsens hypoproteinemia.

Inadequate Immunosuppressive Therapy

Cats with IBD require adequate immunosuppressive therapy. Failure to use appropriate doses or duration leads to relapse. Use prednisolone as first-line therapy and add chlorambucil or cyclosporine for refractory cases.

Failure to Monitor for Relapse

Hypoproteinemia often relapses after initial treatment. Regular monitoring of albumin and clinical signs is essential for early detection and management of relapse.

Welfare and Safety Context

Animal Welfare Considerations

Hypoproteinemia causes significant morbidity in cats. Edema, ascites, and pleural effusion cause discomfort and respiratory compromise. Weight loss and muscle wasting reduce quality of life. Prompt diagnosis and treatment are essential for animal welfare.

Safety Considerations for Veterinary Personnel

Handling cats with hypoproteinemia requires caution. Cats may be weak, dehydrated, or have compromised immune function. Use appropriate restraint techniques. Wear gloves when handling feces or urine. Follow standard infection control protocols.

Regulatory Considerations

The World Organisation for Animal Health (WOAH) provides standards for animal health and welfare. The International Cat Care guidelines from catvets.com offer practical recommendations for feline medicine. The American College of Veterinary Internal Medicine (ACVIM) publishes consensus statements on protein-losing diseases.

Professional Escalation Criteria

When to Refer to a Specialist

Refer to a veterinary internal medicine specialist when:

• The underlying cause is not identified after initial diagnostic workup
• The cat does not respond to initial therapy
• The cat requires advanced diagnostic procedures such as endoscopy, biopsy, or imaging
• The cat has complications such as severe edema, ascites, or pleural effusion
• The cat has concurrent diseases that complicate management

When to Hospitalize

Hospitalize the cat when:

• Albumin is less than 1.5 g/dL
• The cat has severe edema, ascites, or pleural effusion
• The cat is dehydrated or in shock
• The cat has hepatic encephalopathy
• The cat requires intravenous fluids or nutritional support

When to Consider Euthanasia

Consider euthanasia when:

• The underlying cause is untreatable and the cat has poor quality of life
• The cat has end-stage renal or hepatic disease
• The cat has severe, unresponsive disease
• The cat has significant pain or suffering that cannot be controlled

Practical Decision Framework for Differentiating Protein-Losing Enteropathy from Protein-Losing Nephropathy in Cats

Differentiating protein-losing enteropathy (PLE) from protein-losing nephropathy (PLN) is the most common diagnostic challenge in feline hypoproteinemia. Both conditions present with hypoalbuminemia and can occur concurrently in some cats. A structured decision framework using sequential laboratory testing, clinical scoring, and response monitoring helps clinicians reach an accurate diagnosis without unnecessary invasive procedures. This section provides a practical algorithm, record system, and troubleshooting method based on published veterinary guidelines and clinical evidence.

Sequential Diagnostic Algorithm for PLE versus PLN

The decision framework begins with three initial laboratory tests: serum albumin concentration, urine protein:creatinine (UPC) ratio, and fecal alpha-1 protease inhibitor (fAI) concentration. These tests are noninvasive, widely available, and provide complementary information about protein loss routes.

Step 1: Measure UPC Ratio

Perform a UPC ratio on a free-catch or cystocentesis urine sample. A UPC ratio below 0.2 in cats is considered normal. A UPC ratio between 0.2 and 0.5 is borderline and requires repeat testing. A UPC ratio above 0.5 indicates significant proteinuria and raises suspicion for PLN. The Merck Veterinary Manual provides reference ranges for feline urinalysis interpretation.

Step 2: Measure Fecal Alpha-1 Protease Inhibitor

Collect a fresh fecal sample (minimum 2 grams) and submit for fAI measurement. A fAI concentration above the laboratory reference range supports intestinal protein loss. This test has high specificity for PLE when other causes of hypoproteinemia are excluded. The Veterinary Clinics of North America: Small Animal Practice article on protein-losing enteropathies in dogs discusses the diagnostic utility of this test.

Step 3: Apply the Decision Matrix

Use the following matrix to guide next steps:

Step 4: Confirm with Advanced Diagnostics

When the matrix points to PLE, perform abdominal ultrasound to assess intestinal wall thickness, layering, and lymphadenopathy. Endoscopic or full-thickness intestinal biopsy provides definitive histopathologic diagnosis. When the matrix points to PLN, perform renal ultrasound, blood pressure measurement, and consider renal biopsy for histopathology, immunofluorescence, and electron microscopy.

Clinical Scoring System for PLE versus PLN

A clinical scoring system helps quantify the likelihood of each condition based on history and physical examination findings. Assign points for each criterion present:

PLE Score Criteria (maximum 10 points)

• Chronic diarrhea (more than 3 weeks): 3 points
• Vomiting (more than 2 episodes per week): 2 points
• Weight loss despite normal appetite: 2 points
• Thickened intestinal loops on palpation: 2 points
• Peripheral edema or ascites: 1 point

PLN Score Criteria (maximum 10 points)

• Polyuria and polydipsia: 3 points
• Hypertension (systolic blood pressure above 160 mmHg): 2 points
• Retinal detachment or hypertensive retinopathy: 2 points
• Proteinuria on dipstick (2+ or greater): 2 points
• Peripheral edema or ascites: 1 point

Interpretation

• PLE score 5 or higher: proceed with PLE diagnostic pathway
• PLN score 5 or higher: proceed with PLN diagnostic pathway
• Both scores 5 or higher: pursue full diagnostic workup for both conditions
• Both scores below 5: consider hepatic insufficiency, malnutrition, or other causes

This scoring system is based on clinical patterns described in the ACVIM consensus statements and International Cat Care guidelines from catvets.com.

Record System for Tracking Diagnostic Progress

Maintain a standardized record for each cat with hypoproteinemia to track diagnostic progress and response to therapy. The record should include:

Initial Diagnostic Record

• Date of first hypoproteinemia detection
• Serum albumin concentration (g/dL)
• Total protein concentration (g/dL)
• Globulin concentration (g/dL)
• UPC ratio
• fAI concentration (with laboratory reference range)
• PLE score
• PLN score
• Blood pressure (systolic, diastolic)
• Body weight (kg)
• Body condition score (1-9 scale)

Follow-up Record at Each Visit

• Date
• Serum albumin concentration
• Body weight
• Body condition score
• Clinical signs (diarrhea, vomiting, polyuria, polydipsia)
• UPC ratio (if PLN suspected)
• fAI concentration (if PLE suspected)
• Blood pressure (if PLN suspected)
• Current medications and doses
• Dietary changes

Treatment Response Categories

• Complete response: albumin normalizes and clinical signs resolve
• Partial response: albumin improves by at least 0.5 g/dL but remains below normal
• No response: albumin unchanged or declining
• Relapse: albumin decreases after initial improvement

Record these categories at each follow-up visit to guide treatment adjustments.

Troubleshooting Method for Inconclusive Cases

When initial testing does not clearly differentiate PLE from PLN, use the following troubleshooting approach:

Scenario 1: Normal UPC and Normal fAI with Persistent Hypoalbuminemia

Consider hepatic insufficiency as the primary cause. Measure pre- and post-prandial bile acids. If bile acids are elevated, perform liver biopsy. If bile acids are normal, evaluate for malnutrition, chronic inflammation, or neoplasia. The Veterinary Clinics of North America: Small Animal Practice article on feline hepatic lipidosis provides guidance on liver function testing.

Scenario 2: Elevated UPC and Elevated fAI

This pattern suggests concurrent PLE and PLN. Both conditions can occur together in cats with systemic inflammatory diseases such as feline infectious peritonitis, systemic lupus erythematosus, or chronic inflammatory bowel disease with secondary glomerular injury. Perform a complete diagnostic workup including abdominal ultrasound, renal ultrasound, intestinal biopsy, and renal biopsy. Treat both conditions simultaneously.

Scenario 3: Borderline UPC (0.2-0.5) and Normal fAI

Repeat UPC ratio in 2 to 4 weeks. If UPC remains borderline, perform a urine sediment examination to rule out lower urinary tract inflammation or infection. Consider a urine culture if sediment is abnormal. If UPC increases above 0.5, proceed with PLN diagnostic pathway. If UPC remains borderline and fAI remains normal, evaluate for hepatic insufficiency or malnutrition.

Scenario 4: Normal UPC and Elevated fAI with No Gastrointestinal Signs

Some cats with PLE do not have diarrhea or vomiting. Perform abdominal ultrasound to assess intestinal wall thickness. Consider endoscopic biopsy even without gastrointestinal signs. The Frontiers in Veterinary Science article on canine chronic enteropathy discusses subclinical intestinal inflammation that may apply to cats.

Scenario 5: Both Tests Normal but Clinical Suspicion Remains High

Repeat both tests in 4 to 6 weeks. Some cats have intermittent protein loss. If repeat testing remains normal, consider less common causes such as cardiac disease causing protein-losing enteropathy, or paraneoplastic syndromes. The Veterinary Clinics of North America: Small Animal Practice article on laboratory abnormalities in patients with cancer discusses paraneoplastic protein loss.

Comparison of Diagnostic Approaches for PLE and PLN

Common Failure Patterns in Differentiating PLE from PLN

Failure Pattern 1: Relying on UPC Ratio Alone

Some clinicians assume that a normal UPC ratio rules out PLN. However, early PLN may have intermittent proteinuria. Repeat UPC testing is essential. The ACVIM consensus statements recommend at least two UPC measurements before excluding PLN.

Failure Pattern 2: Ignoring Concurrent Disease

Cats can have both PLE and PLN simultaneously. This occurs most commonly with systemic inflammatory diseases. Always consider concurrent disease when diagnostic tests are discordant or when the cat does not respond to therapy.

Failure Pattern 3: Performing Invasive Biopsy Without Noninvasive Testing

Intestinal or renal biopsy carries risks including anesthesia complications, bleeding, and infection. The Journal of Veterinary Medical Science article on barium peritonitis in small animals discusses complications of gastrointestinal procedures. Always perform noninvasive testing first to guide biopsy decisions.

Failure Pattern 4: Not Repeating Borderline Results

Borderline UPC or fAI results should be repeated in 2 to 4 weeks. A single borderline result does not confirm or exclude either condition. Serial testing improves diagnostic accuracy.

Failure Pattern 5: Treating Without a Definitive Diagnosis

Empiric treatment for PLE or PLN without a definitive diagnosis can delay appropriate therapy and worsen outcomes. Always pursue a definitive diagnosis before initiating long-term immunosuppressive or renoprotective therapy.

Welfare and Safety Context for Diagnostic Procedures

Animal Welfare Considerations

Noninvasive testing (UPC ratio, fAI) causes minimal stress to the cat. Abdominal ultrasound requires restraint but is generally well tolerated. Endoscopic biopsy requires general anesthesia and carries risks of aspiration, hypothermia, and prolonged recovery. Full-thickness intestinal biopsy carries higher surgical risks. Renal biopsy carries risks of hemorrhage and renal injury. The World Organisation for Animal Health (WOAH) provides standards for animal health and welfare that apply to diagnostic procedures.

Safety Considerations for Veterinary Personnel

Handling urine and fecal samples requires standard infection control precautions. Wear gloves and wash hands thoroughly. Cats with suspected infectious causes of PLE or PLN may shed pathogens. Follow institutional biosafety protocols.

Professional Escalation Criteria

Refer to a veterinary internal medicine specialist when:

• The diagnostic algorithm does not yield a clear diagnosis after noninvasive testing
• The cat requires endoscopic or surgical biopsy
• The cat has concurrent PLE and PLN requiring coordinated management
• The cat does not respond to initial therapy after 4 weeks
• The cat develops complications such as severe edema, ascites, or pleural effusion

Hospitalize the cat when albumin falls below 1.5 g/dL, when the cat has severe edema or effusion causing respiratory compromise, or when the cat requires intravenous fluid therapy or nutritional support.

Practical Implementation Steps for the Decision Framework

Step 1: Collect Baseline Data

Obtain serum biochemistry, urinalysis with UPC ratio, and fecal sample for fAI. Calculate PLE and PLN scores based on history and physical examination.

Step 2: Apply the Decision Matrix

Use the UPC ratio and fAI concentration to determine the next diagnostic step. Document the interpretation in the medical record.

Step 3: Perform Confirmatory Testing

Based on the matrix, perform abdominal ultrasound or renal ultrasound. Consider biopsy if indicated.

Step 4: Initiate Targeted Therapy

Begin treatment for the confirmed diagnosis. For PLE, start dietary modification and immunosuppressive therapy. For PLN, start ACE inhibitors and dietary protein restriction.

Step 5: Monitor Response

Repeat serum albumin, UPC ratio, and fAI at 2 to 4 week intervals. Adjust therapy based on response.

Step 6: Troubleshoot Non-Responders

If the cat does not respond to therapy, repeat the diagnostic algorithm. Consider concurrent disease, incorrect diagnosis, or treatment failure.

Records and Measurements for the Decision Framework

Maintain the following records for each cat:

• Initial diagnostic record with all test results and scores
• Follow-up records at each visit
• Treatment response categories
• Complications and adverse events
• Referral communications

Use these records to track diagnostic accuracy and treatment outcomes over time. The International Cat Care guidelines from catvets.com recommend standardized record keeping for feline patients.

Summary of the Decision Framework

The decision framework for differentiating PLE from PLN in cats uses sequential noninvasive testing, clinical scoring, and response monitoring to reach an accurate diagnosis. The UPC ratio and fAI concentration provide complementary information about protein loss routes. The clinical scoring system quantifies the likelihood of each condition based on history and physical examination. The troubleshooting method addresses inconclusive cases. This framework reduces unnecessary invasive procedures, improves diagnostic accuracy, and guides targeted therapy.

Frequently Asked Questions

What is the most common cause of hypoproteinemia in cats?

The most common cause of hypoproteinemia in cats is protein-losing enteropathy due to inflammatory bowel disease or intestinal lymphoma. Protein-losing nephropathy and hepatic insufficiency are less common but should be considered in the differential diagnosis.

How do I differentiate protein-losing enteropathy from protein-losing nephropathy?

Differentiation relies on history, physical examination, and laboratory findings. Cats with PLE typically have gastrointestinal signs such as diarrhea and vomiting. Cats with PLN typically have polyuria, polydipsia, and proteinuria. Urine protein:creatinine ratio and fecal alpha-1 protease inhibitor testing help confirm the diagnosis.

What is the role of fecal alpha-1 protease inhibitor testing in feline hypoproteinemia?

Fecal alpha-1 protease inhibitor testing is a noninvasive method to confirm intestinal protein loss. A high fAI concentration supports a diagnosis of PLE. This test is particularly useful when intestinal biopsy is not feasible or when the cat is unstable for anesthesia.

When should I perform intestinal biopsy in a cat with hypoproteinemia?

Intestinal biopsy is indicated when PLE is suspected and the underlying cause is not identified by noninvasive testing. Biopsy is also indicated when the cat does not respond to initial therapy. Endoscopic biopsy is less invasive than full-thickness surgical biopsy.

What is the treatment for protein-losing enteropathy in cats?

Treatment of PLE focuses on treating the underlying disease and providing nutritional support. Dietary modification with a highly digestible, low-residue diet is recommended. Immunosuppressive therapy with prednisolone is indicated for IBD. Chemotherapy is indicated for lymphoma.

What is the treatment for protein-losing nephropathy in cats?

Treatment of PLN focuses on reducing proteinuria and preserving renal function. Angiotensin-converting enzyme inhibitors such as enalapril or benazepril are first-line therapy. Dietary protein restriction is recommended. Immunosuppressive therapy is indicated for immune-mediated glomerulonephritis.

Can hypoproteinemia be cured in cats?

Hypoproteinemia can be cured if the underlying cause is treatable. IBD has a fair to good prognosis with appropriate therapy. Lymphoma has a guarded prognosis. Glomerulonephritis has a guarded to poor prognosis. Hepatic insufficiency has a variable prognosis depending on the cause.

What is the prognosis for a cat with hypoproteinemia?

Prognosis depends on the underlying cause and stage of disease. Cats with IBD have a fair to good prognosis with appropriate therapy. Cats with lymphoma have a guarded prognosis. Cats with glomerulonephritis have a guarded to poor prognosis. Cats with hepatic insufficiency have a variable prognosis.

Related Veterinary Guides

• Cat
• Chronic Kidney Disease In Cats
• Cat Urinary Tract Diet
• Symptoms Of Kidney Disease In My Cat
• Symptoms Of Kidney Disease In Old Cats

References and Further Reading

• www.merckvetmanual.com
• catvets.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Feline Hepatic Lipidosis.. The Veterinary clinics of North America. Small animal practice, 2017.
• [Therapy of canine parvovirus infection - review and current insights].. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere, 2020.
• Treating Hypoalbuminemia.. The Veterinary clinics of North America. Small animal practice, 2017.
• Protein-losing enteropathies in dogs.. The Veterinary clinics of North America. Small animal practice, 2011.
• Barium peritonitis in small animals.. The Journal of veterinary medical science, 2014.
• Laboratory abnormalities in patients with cancer.. The Veterinary clinics of North America. Small animal practice, 1990.
• The Collaborative Collapse: Bile Acid Dysmetabolism as a Central Pathogenic Driver in Canine and Feline Multi-Systemic Disorders-From Mechanisms to Precision Therapeutics. Veterinary Sciences, 2026.
• Canine chronic enteropathy-Current state-of-the-art and emerging concepts. Frontiers in Veterinary Science, 2022.
• Special and novel physiological functions of vitamin D in dogs and cats. Magyar Allatorvosok Lapja, 2022.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.